The University of Chicago Header Logo

Connection

Peter Sand to Adult

Back to Details
This is a "connection" page, showing publications Peter Sand has written about Adult.
Peter Sand
Connection Strength
0.752
Adult
  1. Sexual function in women with anal incontinence using a new instrument: the PISQ-IR. Int Urogynecol J. 2015 May; 26(5):657-63.
    View in: PubMed
    Score: 0.031
  2. Vesico-ureteral reflux in women with idiopathic high-pressure detrusor overactivity: prevalence, bladder function, and effect on the upper urinary tract. Int Urogynecol J. 2014 Oct; 25(10):1405-10.
    View in: PubMed
    Score: 0.030
  3. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep; 190(3):958-64.
    View in: PubMed
    Score: 0.028
  4. Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2013 Feb; 24(2):303-11.
    View in: PubMed
    Score: 0.026
  5. Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies. Drugs Aging. 2012 Feb 01; 29(2):119-31.
    View in: PubMed
    Score: 0.026
  6. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35.
    View in: PubMed
    Score: 0.021
  7. Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. Pharmacoeconomics. 2009; 27(4):329-39.
    View in: PubMed
    Score: 0.021
  8. Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol. 2008 Dec; 199(6):696.e1-7.
    View in: PubMed
    Score: 0.020
  9. Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis. Am J Obstet Gynecol. 2008 Jul; 199(1):71.e1-10.
    View in: PubMed
    Score: 0.020
  10. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin. 2008 Aug; 24(8):2259-64.
    View in: PubMed
    Score: 0.020
  11. Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul; 19(7):991-4.
    View in: PubMed
    Score: 0.020
  12. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology. 2008 Jan; 71(1):57-61.
    View in: PubMed
    Score: 0.019
  13. Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int. 2007 Feb; 99(2):247-62.
    View in: PubMed
    Score: 0.018
  14. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int. 2007 Apr; 99(4):836-44.
    View in: PubMed
    Score: 0.018
  15. Is transobturator tape as effective as tension-free vaginal tape in patients with borderline maximum urethral closure pressure? Am J Obstet Gynecol. 2006 Dec; 195(6):1799-804.
    View in: PubMed
    Score: 0.018
  16. Disruptive effects of overactive bladder and urge urinary incontinence in younger women. Am J Med. 2006 Mar; 119(3 Suppl 1):16-23.
    View in: PubMed
    Score: 0.017
  17. Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol. 2005 Dec; 193(6):2149-53.
    View in: PubMed
    Score: 0.017
  18. Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep; 17(5):449-54.
    View in: PubMed
    Score: 0.017
  19. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun; 17(4):346-51.
    View in: PubMed
    Score: 0.017
  20. Urinary incontinence after multiple gestation and delivery: impact on quality of life. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct; 16(5):334-6.
    View in: PubMed
    Score: 0.016
  21. Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review. Expert Opin Pharmacother. 2004 Nov; 5(11):2351-9.
    View in: PubMed
    Score: 0.016
  22. Prevalence of anal incontinence among mothers of multiples and analysis of risk factors. Am J Obstet Gynecol. 2003 Dec; 189(6):1627-30; discussion 1630-1.
    View in: PubMed
    Score: 0.015
  23. Urinary incontinence among mothers of multiples: the protective effect of cesarean delivery. Am J Obstet Gynecol. 2003 Jun; 188(6):1447-50; discussion 1450-3.
    View in: PubMed
    Score: 0.014
  24. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001 Dec; 185(6):1307-12; discussion 1312-3.
    View in: PubMed
    Score: 0.013
  25. Anterior or posterior sacrospinous vaginal vault suspension: long-term anatomic and functional evaluation. Obstet Gynecol. 2001 Aug; 98(2):199-204.
    View in: PubMed
    Score: 0.012
  26. Comparison of microtransducer and fiberoptic catheters for urodynamic studies. Obstet Gynecol. 2001 Aug; 98(2):253-7.
    View in: PubMed
    Score: 0.012
  27. Anterior Colporrhaphy With and Without Dermal Allograft: A Randomized Control Trial With Long-Term Follow-Up. Female Pelvic Med Reconstr Surg. 2019 May-Jun; 25(3):206-212.
    View in: PubMed
    Score: 0.011
  28. Effect of a urinary control insert on quality of life in incontinent women. Int Urogynecol J Pelvic Floor Dysfunct. 1999; 10(2):100-5.
    View in: PubMed
    Score: 0.010
  29. Is There a Relationship Between Patient-Reported Satisfaction and Persistence on Overactive Bladder Syndrome Pharmacotherapy? Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):237-240.
    View in: PubMed
    Score: 0.010
  30. Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective study. Int Urogynecol J. 2017 Sep; 28(9):1335-1340.
    View in: PubMed
    Score: 0.009
  31. The evaluation and management of hematuria in women. Int Urogynecol J Pelvic Floor Dysfunct. 1997; 8(3):156-60.
    View in: PubMed
    Score: 0.009
  32. Pelvic floor stimulation in the treatment of mixed incontinence complicated by a low-pressure urethra. Obstet Gynecol. 1996 Nov; 88(5):757-60.
    View in: PubMed
    Score: 0.009
  33. The empty supine stress test as a predictor of intrinsic urethral sphincter dysfunction. Obstet Gynecol. 1996 Jul; 88(1):128-32.
    View in: PubMed
    Score: 0.009
  34. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2015 Jan; 34(1):37-43.
    View in: PubMed
    Score: 0.007
  35. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2013 Jul; 24(7):1091-103.
    View in: PubMed
    Score: 0.007
  36. Enhanced interpretability of the PFDI-20 with establishment of reference scores among women in the general population. Neurourol Urodyn. 2012 Nov; 31(8):1252-7.
    View in: PubMed
    Score: 0.007
  37. Simple standing incremental cystometry as a screening method for detrusor instability. Obstet Gynecol. 1991 Mar; 77(3):453-7.
    View in: PubMed
    Score: 0.006
  38. Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin. 2011 May; 27(5):921-30.
    View in: PubMed
    Score: 0.006
  39. Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):251-255.
    View in: PubMed
    Score: 0.006
  40. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) & grafts in female pelvic floor surgery. Int Urogynecol J. 2011 Jan; 22(1):3-15.
    View in: PubMed
    Score: 0.006
  41. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011 Jan; 30(1):2-12.
    View in: PubMed
    Score: 0.006
  42. Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference. Clin Drug Investig. 2011; 31(8):559-571.
    View in: PubMed
    Score: 0.006
  43. The prognostic significance of augmentation of urethral closure pressure and functional length. Int J Gynaecol Obstet. 1990 Oct; 33(2):135-9.
    View in: PubMed
    Score: 0.006
  44. Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J. 2010 Aug; 21(8):939-46.
    View in: PubMed
    Score: 0.006
  45. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 2: Urodynamic testing in male patients with symptoms of urinary incontinence, in patients with relevant neurological abnormalities, and in children and in frail elderly with symptoms of urinary incontinence. Neurourol Urodyn. 2010; 29(1):146-52.
    View in: PubMed
    Score: 0.006
  46. Urinary frequency and urgency. Obstet Gynecol Clin North Am. 1989 Dec; 16(4):883-96.
    View in: PubMed
    Score: 0.006
  47. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol. 2009 Apr; 181(4):1764-72.
    View in: PubMed
    Score: 0.005
  48. The effect of retropubic urethropexy on detrusor stability. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):818-22.
    View in: PubMed
    Score: 0.005
  49. Impact of hysterectomy on stress urinary incontinence: an identical twin study. Am J Obstet Gynecol. 2008 May; 198(5):565.e1-4.
    View in: PubMed
    Score: 0.005
  50. Incontinence history as a predictor of detrusor stability. Obstet Gynecol. 1988 Feb; 71(2):257-60.
    View in: PubMed
    Score: 0.005
  51. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94.
    View in: PubMed
    Score: 0.005
  52. Supine urethroscopic and standing cystometry as screening methods for the detection of detrusor instability. Obstet Gynecol. 1987 Jul; 70(1):57-60.
    View in: PubMed
    Score: 0.005
  53. Cryotherapy for the treatment of proximal urethral condyloma acuminatum. J Urol. 1987 May; 137(5):874-6.
    View in: PubMed
    Score: 0.005
  54. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007 May; 69(5):876-80.
    View in: PubMed
    Score: 0.005
  55. Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
    View in: PubMed
    Score: 0.005
  56. The low pressure urethra as a factor in failed retropubic urethropexy. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):399-402.
    View in: PubMed
    Score: 0.005
  57. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther. 2006 Nov; 28(11):1935-46.
    View in: PubMed
    Score: 0.004
  58. Evaluation of male consorts of women with genital human papilloma virus infection. Obstet Gynecol. 1986 Nov; 68(5):679-81.
    View in: PubMed
    Score: 0.004
  59. Perceptions and behaviours of women with bladder control problems. Fam Pract. 2006 Oct; 23(5):568-77.
    View in: PubMed
    Score: 0.004
  60. Effect of parity on sexual function: an identical twin study. Obstet Gynecol. 2006 Apr; 107(4):765-70.
    View in: PubMed
    Score: 0.004
  61. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol. 2005 Oct; 106(4):726-32.
    View in: PubMed
    Score: 0.004
  62. The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery. Obstet Gynecol. 2005 Oct; 106(4):782-8.
    View in: PubMed
    Score: 0.004
  63. Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology. 2004 Apr; 63(4):704-8.
    View in: PubMed
    Score: 0.004
  64. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl. 2004; (68):147-56.
    View in: PubMed
    Score: 0.004
  65. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
    View in: PubMed
    Score: 0.003
  66. Update on extracorporeal magnetic innervation (EXMI) therapy for stress urinary incontinence. Urology. 2000 Dec 04; 56(6 Suppl 1):82-6.
    View in: PubMed
    Score: 0.003
  67. Extracorporeal magnetic innervation therapy for stress urinary incontinence. Urology. 1999 Jun; 53(6):1108-11.
    View in: PubMed
    Score: 0.003
  68. Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology. 1997 Dec; 50(6):934-40.
    View in: PubMed
    Score: 0.002
  69. Effectiveness of a urinary control insert in the management of stress urinary incontinence: early results of a multicenter study. Urology. 1996 May; 47(5):629-36.
    View in: PubMed
    Score: 0.002
  70. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology. 1996 Jan; 21(1):25-31.
    View in: PubMed
    Score: 0.002
  71. [Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients]. Psychiatr Prax. 1993 Sep; 20(5):172-5.
    View in: PubMed
    Score: 0.002
  72. Unsuccessful Burch retropubic urethropexy: a case-controlled urodynamic study. Am J Obstet Gynecol. 1989 Feb; 160(2):452-8.
    View in: PubMed
    Score: 0.001
  73. A urodynamic appraisal of success and failure after retropubic urethropexy. J Reprod Med. 1987 Sep; 32(9):693-6.
    View in: PubMed
    Score: 0.001
  74. Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol. 1986 Jun; 154(6):1299-306.
    View in: PubMed
    Score: 0.001
  75. Toxic shock syndrome following carbon dioxide laser treatment of genital tract condyloma acuminatum. Am J Obstet Gynecol. 1986 Jan; 154(1):145-6.
    View in: PubMed
    Score: 0.001
  76. Pregnancy outcome subsequent to consecutive hydatidiform moles. Am J Obstet Gynecol. 1982 Apr 15; 142(8):1060-1.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.